Loading clinical trials...
Loading clinical trials...
SARS-COV-2 Prevalence, Seroprevalence and Seroconversion Among Healthcare Workers in Belgium During the 2020 COVID-19 Outbreak
Conditions
Locations
1
Belgium
Sciensano
Brussels, Belgium
Start Date
April 22, 2020
Primary Completion Date
April 30, 2021
Completion Date
April 30, 2021
Last Updated
October 4, 2021
NCT06082518
NCT07221162
NCT06631287
NCT05141058
NCT06679140
NCT06417762
Lead Sponsor
Sciensano
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions